Frazier Life Sciences Management, L.P. - REPLIMUNE GROUP INC ownership

REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 134 filers reported holding REPLIMUNE GROUP INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.

Quarter-by-quarter ownership
Frazier Life Sciences Management, L.P. ownership history of REPLIMUNE GROUP INC
ValueSharesWeighting
Q3 2023$6,617,498
-26.3%
386,7620.0%0.44%
-17.9%
Q2 2023$8,980,614
-26.0%
386,762
-43.7%
0.54%
-39.0%
Q1 2023$12,128,217
-52.1%
686,762
-26.3%
0.88%
-44.3%
Q4 2022$25,338,432
+82.0%
931,560
+15.5%
1.58%
+46.9%
Q3 2022$13,924,000
-1.2%
806,2670.0%1.07%
-19.4%
Q2 2022$14,094,000
+15.8%
806,267
+12.5%
1.33%
+28.3%
Q1 2022$12,171,000716,7621.04%
Other shareholders
REPLIMUNE GROUP INC shareholders Q3 2023
NameSharesValueWeighting ↓
Omega Fund Management, LLC 3,001,319$51,352,56847.17%
Atlas Venture Life Science Advisors, LLC 2,098,300$35,901,9135.56%
Redmile Group, LLC 4,163,922$71,244,7053.39%
Nan Fung Group Holdings Ltd 184,739$3,160,8842.56%
GREAT POINT PARTNERS LLC 638,495$10,924,6491.99%
ACUTA CAPITAL PARTNERS, LLC 150,000$2,566,5001.72%
Ghost Tree Capital, LLC 250,000$4,277,5001.41%
Altium Capital Management LP 155,000$2,652,0501.38%
ACUTA CAPITAL PARTNERS, LLC 1,000$1,766,0001.18%
Camber Capital Management LP 2,000,000$34,2201.13%
View complete list of REPLIMUNE GROUP INC shareholders